Celldex Therapeutics to Present at H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference

Celldex Therapeutics (NASDAQ:CLDX) will participate in a fireside chat at the H.C.

Rhea-AI Summary

Celldex Therapeutics (NASDAQ:CLDX) will participate in a fireside chat at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference on March 30, 2023, at 11:30 am ET. The event will be accessible via a webcast on the company's website, with a replay available for 90 days post-event. Celldex is a clinical-stage biotechnology firm focusing on developing monoclonal and bispecific antibodies to treat severe diseases. Their innovative therapeutics aim to engage the immune system or target critical pathways, enhancing treatment options for patients with inflammatory diseases and various cancers.

Argus Session date unavailable

+3.39% session move Open Argus

Details

News Market Reaction – CLDX

The recorded move for CLDX in the trading session of this news was +3.39%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

HAMPTON, N.J., March 29, 2023 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference on Thursday, March 30^th at 11:30 am ET. A webcast of the presentation will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay will be available for 90 days following the event.

About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit www.celldex.com.

Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com

Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is the Celldex Therapeutics fireside chat at the H.C. Wainwright Conference?

The fireside chat will take place on March 30, 2023, at 11:30 am ET.

How can I access the Celldex Therapeutics conference presentation?

The presentation will be available via webcast on Celldex's 'Events & Presentations' page.

Will there be a replay of the Celldex conference presentation?

Yes, a replay will be available for 90 days following the event.

What does Celldex Therapeutics focus on?

Celldex is dedicated to developing monoclonal and bispecific antibodies for treating inflammatory diseases and various forms of cancer.